TG THERAPEUTICS INC (TGTX)
NASDAQ • Healthcare
Last close at August 11, 2026 at 20:00 UTC
Fundamentals Charts
About TG THERAPEUTICS INC
TG Therapeutics, Inc. is a commercial-stage biotechnology company listed on the NASDAQ as TGTX that develops and sells therapies for B-cell related cancers and autoimmune disorders. FY2025 revenue was $616.3 million. Its business centers on monoclonal antibodies, targeted oral inhibitors, and earlier licensed programs in immunology and oncology.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
TG THERAPEUTICS INC's Technical Indicators Summary
TGTX is tilted toward weakness as recent momentum has softened and volume trends are negative. The MACD and short-term momentum readings are bearish, while oscillators sit in neutral territory, indicating limited immediate buying pressure. Price lies below several medium-term averages even though it remains above longer-term bands, producing a mixed timeframe profile that favors the near-term sellers. ADX suggests a developing directional bias and ATR shows moderate volatility, while pivots are neutral. Technical takeaway: the balance of weakening momentum and negative volume supports a sell stance.
| Indicator | Value |
|---|---|
RSI (14) | 44.82 |
Stochastic %K (14, 3, 3) | 35.45 |
CCI (20) | -58.69 |
WPR (14) | -61.79 |
Momentum (10) | -3.45 |
MFI | 28.53 |
MACD Level (12, 26) | -0.89 |
Bollinger Bands | $46.51 - $57.96 |
ATR (14) | $2.16 (4.32%) |
ADX (14) | 25.11 |
OBV | 63,789,451 |
Classic Pivot Point | $49.75 |
Fibonacci Pivot Point | $49.75 |
Simple Moving Averages | $37.26 - $52.24(5 indicators) |
Exponential Moving Averages | $40.14 - $51.45(5 indicators) |
Get premium market insights delivered directly to your inbox.